Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)

Market Cap	5.15B +6.8%
Revenue (ttm)	2.54B -11.5%
Net Income	47.11M +196.1%
EPS	0.04 +201.6%
Shares Out	1.09B
PE Ratio	108.05
Forward PE	n/a
Dividend	0.05 (1.10%)
Ex-Dividend Date	Jul 14, 2026

Volume	42,835,000
Open	4.930
Previous Close	4.930
Day's Range	4.700 - 4.930
52-Week Range	3.680 - 8.440
Beta	0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2026

About SHA:600488

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company’s primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, betamethasone product series, and other hormone precursors. The company provides amino acid raw materials, as well as preparations, including injections, ointments, creams, hard capsules, pills, freeze-dried powder inj...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 2,731
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600488

Financial Performance

In 2025, SHA:600488's revenue was 2.91 billion, a decrease of -9.56% compared to the previous year's 3.22 billion. Earnings were 70.56 million, a decrease of -47.12%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error